Health Policy
Commentary
Introduction
Like the flip of a light switch, the world in March 2020 went into lockdown. Suddenly the novel coronavirus disease (COVID-19) was ever-present...
Commentary
Foreword: VA Research and COVID-19
The impressive collection of articles in this special issue provides a snapshot of the large-scale, all-hands approach the VHA adopted during the...
News
VA and Non-VA Partners Improving Care by Sharing Data
The US Department of Veterans Affairs (VA) and 13 health care systems have signed a...
News
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.
Latest News
FDA approves new drug to manage menopausal hot flashes
Fezolinetant (Veozah) targets the neural activity behind moderate to severe vasomotor symptoms.
News
FDA OKs new drug for Fabry disease
“The totality of clinical data suggests that Elfabrio has the potential to be a long-lasting therapy.”
News
FDA approves first drug to treat Alzheimer’s agitation
“Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease.”
Latest News
Medical students gain momentum in effort to ban legacy admissions
Opponents of legacy admissions say it penalizes students from racial minorities and lower socioeconomic backgrounds, hampering a fair and...
Conference Coverage
New protocol could cut fasting period to detect insulinomas
“These data support a 48-hour fast. The literature supports that’s sufficient to detect 95% of insulinomas.”
News
New USPSTF draft suggests mammography start at 40, not 50
“It is now clear that screening every other year starting at age 40 has the potential to save about 20% more lives among all women.”